FDA regulatory clearance or approval is a prerequisite for most electromedical and electrotherapeutic devices entering US commerce, making pre-import classification under the correct device code a critical compliance step. Products in this sector range from diagnostic imaging equipment and ultrasound systems to electrotherapy and neurostimulation devices, each potentially subject to distinct 510(k) or PMA pathways. Many finished devices and subassemblies sourced from Asia are subject to Section 301 tariffs, adding landed-cost complexity for importers. Accurate HTS classification is essential because misclassification can trigger both duty underpayment liability and FDA admissibility holds.

AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.